Which imaging modality is used to diagnose benign soft tissue tumors of the chest wall?

Which imaging modality is used to diagnose benign soft tissue tumors of the chest wall?

• A. MRI
• B. CT
• C. X-ray
• D. PET

Answer: (A)

MRI is favored because it provides superior soft tissue contrast and multiplanar detail, which is essential for accurately characterizing chest wall soft tissue tumors and defining their full extent. This imaging helps distinguish different tissue components—fat, fibrous tissue, fluid, and vascular elements—and can show how a lesion relates to the ribs, intercostal muscles, pleura, and other chest wall structures. For fat-containing lesions, fat-saturation techniques can confirm fat content and help separate benign lipomas from liposarcomas. MRI also demonstrates enhancement patterns after contrast, which aids in assessing benignity versus potential malignancy and in planning surgical resection. CT has strengths in evaluating bone involvement and calcifications, but its soft tissue contrast is inferior to MRI. X-ray offers limited information about soft tissues, and PET is a metabolic study more useful when malignancy is suspected rather than for diagnosing benign chest wall tumors.

MRI is favored because it provides superior soft tissue contrast and multiplanar detail, which is essential for accurately characterizing chest wall soft tissue tumors and defining their full extent. This imaging helps distinguish different tissue components—fat, fibrous tissue, fluid, and vascular elements—and can show how a lesion relates to the ribs, intercostal muscles, pleura, and other chest wall structures. For fat-containing lesions, fat-saturation techniques can confirm fat content and help separate benign lipomas from liposarcomas. MRI also demonstrates enhancement patterns after contrast, which aids in assessing benignity versus potential malignancy and in planning surgical resection.

CT has strengths in evaluating bone involvement and calcifications, but its soft tissue contrast is inferior to MRI. X-ray offers limited information about soft tissues, and PET is a metabolic study more useful when malignancy is suspected rather than for diagnosing benign chest wall tumors.